Current Treatment of the Pulmonary Arterial Hypertension

被引：0

作者：

Gallego-Page, Juan C. ^{[1
]}

机构：

[1] Complejo Hosp Albacete, Pulm Hypertens & Heart Failure Unit, Dept Cardiol, Albacete, Spain

来源：

CURRENT RESPIRATORY MEDICINE REVIEWS | 2007年 / 3卷 / 02期

关键词：

Pulmonary arterial hypertension; treatment;

D O I：

10.2174/157339807780599117

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Pulmonary arterial hypertension is a feature of a spectrum of diseases that includes elevated pulmonary vascular resistance, induces right ventricular insufficiency and heart failure, and threatens the life. The aetiology and pathogenesis is diverse and associated with elevated morbidity and mortality. Treatment is frequently deficient and empirical. Fortunately, in recent years, randomized clinical trials have shown useful effects of various drugs on pulmonary arterial hypertension. This article reviews the pharmacological and not pharmacological therapeutic options to treat pulmonary arterial hypertension and attempts to provide a proposal of algorithm for its management based upon the evidence and available guidelines for clinical management.

引用

页码：129 / 134

页数：6

共 30 条

[1] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].

Badesch, DB ;

Tapson, VF ;

McGoon, MD ;

Brundage, BH ;

Rubin, LJ ;

Wigley, FM ;

Rich, S ;

Barst, RJ ;

Barrett, PS ;

Kral, KM ;

Jöbsis, MM ;

Loyd, JE ;

Murali, S ;

Frost, A ;

Girgis, R ;

Bourge, RC ;

Ralph, DD ;

Elliott, CG ;

Hill, NS ;

Langleben, D ;

Schilz, RJ ;

McLaughlin, VV ;

Robbins, IM ;

Groves, BM ;

Shapiro, S ;

Medsger, TA ;

Gaine, SP ;

Horn, E ;

Decker, JC ;

Knobil, K .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+

[2] Medical therapy for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines [J].

Badesch, DB ;

Abman, SH ;

Ahearn, GS ;

Barst, RJ ;

McCrory, DC ;

Simonneau, G ;

McLaughlin, VV .

CHEST, 2004, 126 (01) :35S-62S

[3] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[4] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

[5] Immediate and long-term hemodynamic and clinical effects of Sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy [J].

Bhatia, S ;

Frantz, RP ;

Severson, CJ ;

Durst, LA ;

McGoon, MD .

MAYO CLINIC PROCEEDINGS, 2003, 78 (10) :1207-1213

[6]

Channick R., 2001, Journal of Heart and Lung Transplantation, V20, P262, DOI 10.1016/S1053-2498(00)00606-9

[7] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].

DALONZO, GE ;

BARST, RJ ;

AYRES, SM ;

BERGOFSKY, EH ;

BRUNDAGE, BH ;

DETRE, KM ;

FISHMAN, AP ;

GOLDRING, RM ;

GROVES, BM ;

KERNIS, JT ;

LEVY, PS ;

PIETRA, GG ;

REID, LM ;

REEVES, JT ;

RICH, S ;

VREIM, CE ;

WILLIAMS, GW ;

WU, M .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349

[8] Surgical treatments/interventions for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines [J].

Doyle, RL ;

McCrory, D ;

Channick, RN ;

Simonneau, G ;

Conte, J .

CHEST, 2004, 126 (01) :63S-71S

[9] Primary pulmonary arterial hypertension - A look back [J].

Fishman, AP .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :2S-4S

[10] The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension [J].

Frank, H ;

Mlczoch, J ;

Huber, K ;

Schuster, E ;

Gurtner, HP ;

Kneussl, M .

CHEST, 1997, 112 (03) :714-721

← 1 2 3 →